HER2 + GASTRIC CANCER
Clinical trials for HER2 + GASTRIC CANCER explained in plain language.
Never miss a new study
Get alerted when new HER2 + GASTRIC CANCER trials appear
Sign up with your email to follow new studies for HER2 + GASTRIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple-Drug attack on Hard-to-Treat stomach cancer shows promise in early trial
Disease control Recruiting nowThis Phase II trial is testing a combination of three drugs—zanidatamab, pembrolizumab, and chemotherapy—in 80 people with advanced stomach or esophageal cancer that has spread and tests positive for HER2 and PD-L1. The goal is to see if this triple therapy can keep the cancer fr…
Matched conditions: HER2 + GASTRIC CANCER
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New pill takes aim at hard-to-treat HER2 cancers
Disease control Recruiting nowThis early-stage trial tests a new drug called IAM1363 in adults with advanced cancers that have HER2 alterations, including breast, lung, and stomach cancers that have spread to the brain. The study aims to find the safest dose and see if the drug can shrink tumors. About 383 pa…
Matched conditions: HER2 + GASTRIC CANCER
Phase: PHASE1 • Sponsor: Iambic Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC